"Papillomavirus Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS.
| Descriptor ID |
D053918
|
| MeSH Number(s) |
D20.215.894.899.498
|
| Concept/Terms |
Human Papillomavirus Vaccines- Human Papillomavirus Vaccines
- Papillomavirus Vaccines, Human
- Vaccines, Human Papillomavirus
- Human Papilloma Virus Vaccines
- HPV Vaccines
|
Below are MeSH descriptors whose meaning is more general than "Papillomavirus Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Papillomavirus Vaccines".
This graph shows the total number of publications written about "Papillomavirus Vaccines" by people in this website by year, and whether "Papillomavirus Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 2 | 0 | 2 |
| 2010 | 2 | 0 | 2 |
| 2011 | 3 | 0 | 3 |
| 2012 | 4 | 3 | 7 |
| 2013 | 3 | 2 | 5 |
| 2014 | 4 | 0 | 4 |
| 2015 | 3 | 0 | 3 |
| 2016 | 4 | 0 | 4 |
| 2017 | 4 | 0 | 4 |
| 2019 | 4 | 0 | 4 |
| 2020 | 5 | 0 | 5 |
| 2021 | 1 | 0 | 1 |
| 2022 | 3 | 1 | 4 |
| 2023 | 2 | 0 | 2 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Papillomavirus Vaccines" by people in Profiles.
-
Immunogenicity and Safety of Extended-Interval 2-Dose Regimens of 9vHPV Vaccine. Pediatrics. 2024 Aug 01; 154(2).
-
Los Angeles County dentists' opinions on discussing human papilloma virus-related oral health issues and recommending vaccine to patients. Hum Vaccin Immunother. 2024 Dec 31; 20(1):2371671.
-
A Learning Health System Approach to Increasing Human Papillomavirus Immunizations Among Young Adults. Perm J. 2023 06 15; 27(2):31-36.
-
Epidemiology of Upper Limb Complex Regional Pain Syndrome in a Retrospective Cohort of Persons Aged 9-30 Years, 2002-2017. Perm J. 2023 06 15; 27(2):75-86.
-
Extended surveillance to assess safety of 9-valent human papillomavirus vaccine. Hum Vaccin Immunother. 2022 12 30; 18(7):2159215.
-
Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California. Vaccine. 2022 11 02; 40(46):6575-6580.
-
Improving HPV Vaccination Rates in a Racially and Ethnically Diverse Pediatric Population. Pediatrics. 2022 10 01; 150(4).
-
A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016. Vaccine. 2022 02 23; 40(9):1246-1252.
-
Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes. JAMA Netw Open. 2021 04 01; 4(4):e214340.
-
A Mixed-Methods Analysis of Barriers to and Facilitators of Human Papillomavirus Vaccination Among Adolescents in Montana. Public Health Rep. 2020 Nov/Dec; 135(6):842-850.